Hepatitis B Virus
New findings from Osaka City University, Medical Department describe advances in hepatitis B virus
Published in Hepatitis Weekly, September 15th, 2008
"The endpoint of treatment with nucleoside analogs remains unclear for patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. We report the results of a randomized trial to determine the optimal duration of additional therapy after response to lamivudine in HBeAg-negative patients. Twenty-two patients with HBeAg-negative chronic hepatitis B who exhibited biochemical and virological responses to lamivudine were enrolled," investigators in Osaka, Japan report.
"When patients responded to treatment, they were randomly assigned to receive 12 more months of therapy (Group A, 11 patients) or 24 more months of therapy (Group B, 11 patients). The baseline...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-09-15)
More Articles from Hepatitis Weekly
- Acute Hepatitis
Findings from C.L. Fan and co-researchers advance knowledge in acute hepatitis - Acute Hepatitis
Researchers at Nagoya University release new data on acute hepatitis - Hepatitis B Virus
Data from P. Turelli and colleagues advance knowledge in hepatitis B virus - Hepatitis B Virus
New hepatitis B virus study findings recently were reported by Y.B. Tang and co-researchers - Hepatitis B Virus
New hepatitis B virus study findings reported from Gifu University, Medical Department - Hepatitis B Virus
New hepatitis B virus study results reported from Dumlupinar University, Medical Department - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
